Clinical Trials and Cohort Studies​

​​

Our team is implementing clinical trials and cohort studies aimed at addressing critical challenges in tuberculosis treatment and prevention. This includes early-phase studies to assess the safety of new drug regimens, and definitive trials that help to evaluate how new options for drug-resistant and drug-susceptible tuberculosis can benefit patients.

​

​

​

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

​